Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Helena H, Askling"'
Publikováno v:
New Microbes and New Infections, Vol 62, Iss , Pp 101465- (2024)
Externí odkaz:
https://doaj.org/article/beb226e5b1bf4603addd94772fd8c21d
Autor:
Sophia Themistocleous, Christos D Argyropoulos, Paris Vogazianos, George Shiamakkides, Evgenia Noula, Andria Nearchou, Andreas Yiallouris, Charalampos Filippou, Fiona A Stewart, Markela Koniordou, Ioannis Kopsidas, Helena H Askling, Sirkka Vene, Amandine Gagneux-Brunon, Jana Baranda Prellezo, Elena Álvarez-Barco, Jon Salmanton-García, Janina Leckler, Alan J Macken, Ruth Joanna Davis, Anna Maria Azzini, Charis Armeftis, Margot Hellemans, Romina Di Marzo, Catarina Luis, Ole F Olesen, Olena Valdenmaiier, Stine Finne Jakobsen, Pontus Nauclér, Odile Launay, Patrick Mallon, Jordi Ochando, Pierre van Damme, Evelina Tacconelli, Theoklis Zaoutis, Oliver A Cornely, Zoi Dorothea Pana
Publikováno v:
JMIR Public Health and Surveillance, Vol 10, p e47241 (2024)
BackgroundThe VACCELERATE Pan-European Scientific network aims to strengthen the foundation of vaccine trial research across Europe by following the principles of equity, inclusion, and diversity. The VACCELERATE Volunteer Registry network provides a
Externí odkaz:
https://doaj.org/article/e3d4a5db9d5c42cfb8c2521ae941c921
Autor:
Martin Angelin, Jan Sjölin, Fredrik Kahn, Anna Ljunghill Hedberg, Anja Rosdahl, Paul Skorup, Simon Werner, Susanne Woxenius, Helena H. Askling
Publikováno v:
Travel Medicine and Infectious Disease, Vol 54, Iss , Pp 102598- (2023)
Qdenga® has been approved by the European Medicines Agency (EMA) for individuals > 4 years of age and for use according to national recommendations. The vaccine shows high efficacy against virologically confirmed dengue and severe dengue in clinical
Externí odkaz:
https://doaj.org/article/f875f822f19a4008ac132eaff93b73b4
Autor:
Lisa Labbé Sandelin, Helena H. Askling
Publikováno v:
New Microbes and New Infections, Vol 53, Iss , Pp 101157- (2023)
Externí odkaz:
https://doaj.org/article/0a6e0ce7d7c94304b6b495bcc34ea159
Autor:
Dimitrios Poulimeneas, Markela Koniordou, Dimitra Kousi, Christina Merakou, Ioannis Kopsidas, Grammatiki Christina Tsopela, Christos D. Argyropoulos, Sophia C. Themistocleous, George Shiamakkides, Marinos Constantinou, Alexandra Alexandrou, Evgenia Noula, Andria Nearchou, Jon Salmanton-García, Fiona A. Stewart, Sarah Heringer, Kerstin Albus, Elena Álvarez-Barco, Alan Macken, Romina Di Marzo, Catarina Luis, Paula Valle-Simón, Helena H. Askling, Margot Hellemans, Orly Spivak, Ruth Joanna Davis, Anna Maria Azzini, Imre Barta, Lenka Součková, Ligita Jancoriene, Murat Akova, Patrick W. G. Mallon, Ole F. Olesen, Jesus Frias-Iniesta, Pierre van Damme, Krisztina Tóth, Miriam Cohen-Kandli, Rebecca Jane Cox, Petr Husa, Pontus Nauclér, Laura Marques, Jordi Ochando, Evelina Tacconelli, Markus Zeitlinger, Oliver A. Cornely, Zoi Dorothea Pana, Theoklis E. Zaoutis
Publikováno v:
Vaccines, Vol 11, Iss 12, p 1784 (2023)
Underserved and hard-to-reach population groups are under-represented in vaccine trials. Thus, we aimed to identify the challenges of vaccine trial participation of these groups in member countries of the VACCELERATE network. Seventeen National Coord
Externí odkaz:
https://doaj.org/article/c10e91baccf94e9faa5c72265d0677bc
Autor:
Berta Olafsdottir, Helena H. Askling
Publikováno v:
New Microbes and New Infections, Vol 48, Iss , Pp 101022- (2022)
Externí odkaz:
https://doaj.org/article/dbacb565a4124a9797713c816bd676e5
Autor:
Martin Neovius, Verena Sengpiel, Olof Stephansson, Jonas F. Ludvigsson, Mia Ahlberg, Mikael Norman, Helena H. Askling, Jerker Jonsson, Emma Appelqvist, Björn Pasternak, Jonas Söderling, Bernice Aronsson
Publikováno v:
Bjog
Objective To assess associations of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and pregnancy outcomes considering testing policy and test‐positivity‐to‐delivery interval. Design Nationwide cohort study. Setting S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98f46356559b73dd2e5b1666ef0e990d
https://doi.org/10.1111/1471-0528.16990
https://doi.org/10.1111/1471-0528.16990
Autor:
Lars Rombo, Sarah Thunberg, Hans-Gustaf Ljunggren, Kim Blom, Helena H. Askling, Margit H. Lampen, Lars Lindquist, Sirkka Vene, Sara Gredmark-Russ, Renata Varnaitė
Publikováno v:
The Journal of Immunology. 204:914-922
Tick-borne encephalitis (TBE) is a viral infection of the CNS caused by TBE virus. With no specific treatment available, the only protection is a formalin-inactivated whole virus vaccine. Primary immunization with European TBE vaccines, as recommende
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a56d43cf2bb9ca9db3212f12faec699f
https://doi.org/10.4049/jimmunol.1901115
https://doi.org/10.4049/jimmunol.1901115
Autor:
Helena H. Askling, Birgitta Lesko, Sirkka Vene, Angerd Berndtson, Per Björkman, Jonas Bläckberg, Ulf Bronner, Per Follin, Urban Hellgren, Maria Palmerus, Karl Ekdahl, Anders Tegnell, Johan Struwe
Publikováno v:
Emerging Infectious Diseases, Vol 15, Iss 11, Pp 1805-1808 (2009)
We studied 1,432 febrile travelers from Sweden who had returned from malaria-endemic areas during March 2005–March 2008. In 383 patients, paired serum samples were blindly analyzed for influenza and 7 other agents. For 21% of 115 patients with feve
Externí odkaz:
https://doaj.org/article/b0f3125222744f8e8ff8a11392caf925
Autor:
Sirkka Vene, Anja Rosdahl, Lars Lindquist, Helena H. Askling, Karin E Hansson, Sara Gredmark-Russ, Mona Insulander
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background Southern Sweden is endemic for tick-borne encephalitis (TBE), with Stockholm County as one of the high-risk areas. Our aim in this study was to describe cases of vaccine failures and to optimize future vaccination recommendations. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43400cbdee68f7c9bb71d043397e6f18
https://doi.org/10.1093/cid/ciz176
https://doi.org/10.1093/cid/ciz176